View all news

Ginkgo Bioworks Announces Participation in Jefferies Virtual Synthetic Biology Week

March 15, 2022

BOSTON, March 15, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that management is scheduled to participate in a fireside chat at Jefferies Virtual Synthetic Biology Week, on March 22, 2022, at 10:00 a.m. Eastern Time.

Further details, a webcast link, and a replay of the fireside chat will be posted on the company's investor relations website at

About Ginkgo Bioworks

Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization, and therapeutics discovery. For more information, visit

Ginkgo Bioworks Contacts: 


Cision View original content to download multimedia:

SOURCE Ginkgo Bioworks

Multimedia Files:

Categories: Press Releases
View all news